Enrolment of 1223 patients in 11 sites across Russia completed

12 February 2010

OCT completed enrolment of 1223 patients in 11 sites across Russia in post- marketing study in pulmonology 1 month ahead.

OCT Vision

“OCT vision is to be recognized by pharmaceutical and biotech companies as a leading provider of clinical trials in Russia, Ukraine, Bulgaria, Belarus, Latvia, Lithuania, Estonia, Poland and Czech Republic. OCT is able to support any requirements that clients may have in the region, ranging from one-off advice to full-study implementation and execution. We are determined and decisive in expanding our activity at this rapidly growing market”— Dmitry Sharov, General Manager of OCT.